The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

• Michael J Campbell,
• Hope S Rugo,
• Chiun-Sheng Huang,
• Chun-Yen Lin,
• Jung-Tung Hung,
• I-Ju Chen,
• Shir-Hwa Ueng,
• Shin-Cheh Chen,
• Mu-Yi Chen,
• Yung-Chang Lin,
• Alice L Yu

Affiliations

Michael J Campbell

School of Health and Related Research, The University of Sheffield, Sheffield, UK

Hope S Rugo

Helen Diller Family Comprehensive Cancer Center, Breast Oncology and Clinical Trials Education, University of California San Francisco, San Francisco, California, USA

Chiun-Sheng Huang

Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan

Chun-Yen Lin

2Chang Gung University College of Medicine, Taoyuan City, Taiwan

Jung-Tung Hung

Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

I-Ju Chen

OBI Pharma Inc, Taipei, Taiwan

Shir-Hwa Ueng

Department of Pathology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

Shin-Cheh Chen

Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

Mu-Yi Chen

OBI Pharma Inc, Taipei, Taiwan

Yung-Chang Lin

Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

Alice L Yu

Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan